These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
308 related items for PubMed ID: 25935193
21. Solitary extramedullary plasmacytoma five years after successful cardiac transplantation: case report and review of the literature. Leigh BR, Larkin EC, Doggett RL. Am J Clin Oncol; 1997 Oct; 20(5):467-70. PubMed ID: 9345329 [Abstract] [Full Text] [Related]
22. Pleural effusion in multiple myeloma. Rodríguez JN, Pereira A, Martínez JC, Conde J, Pujol E. Chest; 1994 Feb; 105(2):622-4. PubMed ID: 8306782 [Abstract] [Full Text] [Related]
23. Auer rod-like inclusions in immunoglobulin a multiple myeloma. V M, Meenu Bal M, Varma N, Sakhuja V. Arch Pathol Lab Med; 2005 May; 129(5):706-7. PubMed ID: 15859651 [No Abstract] [Full Text] [Related]
24. Multiple primary cutaneous plasmacytomas: an unusual presentation. Uçmak D, Meltem Akkurt Z, Türkçü G, Harman M, Sinan Dal M, Uçmak F. J Cutan Med Surg; 2014 Oct; 18(5):361-4. PubMed ID: 25187000 [Abstract] [Full Text] [Related]
26. Crystal-storing histiocytosis. Qureshi A, Kashif M. Blood; 2010 Apr 01; 115(13):2568. PubMed ID: 20373527 [No Abstract] [Full Text] [Related]
27. Solitary and multiple plasmacytoma. Kraj M, Maj S, Wroński D, Letowska M. Acta Med Pol; 1982 Apr 01; 23(1-2):91-103. PubMed ID: 7187604 [No Abstract] [Full Text] [Related]
28. Plasma cells composing plasmacytoma have phenotypes different from those of myeloma cells. Sakai A, Fujii T, Noda M, Hyodo H, Oda K, Kimura A. Am J Hematol; 1996 Dec 01; 53(4):251-3. PubMed ID: 8948665 [Abstract] [Full Text] [Related]
30. Non-excretory IgM-kappa myeloma: report of a case. Wang CR, Tien HF, Hsieh HC, Wang CH, Chuang CY. Taiwan Yi Xue Hui Za Zhi; 1988 Nov 01; 87(11):1108-11. PubMed ID: 3148682 [No Abstract] [Full Text] [Related]
31. Multiple myeloma first observed as multiple cutaneous plasmacytomas. Shah A, Klimo P, Worth A. Arch Dermatol; 1982 Nov 01; 118(11):922-4. PubMed ID: 6814367 [Abstract] [Full Text] [Related]
32. Cutaneous involvement in multiple myeloma and bortezomib. Siniscalchi A, Fratoni S, Santeusanio G, Del Poeta G, de Fabritiis P, Caravita T. Ann Hematol; 2009 Nov 01; 88(11):1137-9. PubMed ID: 19259673 [No Abstract] [Full Text] [Related]
34. Cutaneous plasmacytosis: a clinicopathologic study of 12 cases in Taiwan revealing heterogeneous underlying causes. Lu PH, Shih LY, Yang CH, Kuo TT. Int J Dermatol; 2015 Oct 01; 54(10):1132-7. PubMed ID: 26016536 [Abstract] [Full Text] [Related]
35. Crystalline inclusions in myeloma cells: Need to go beyond morphologic curiosity. Agashe SR, Pol JN, Kadkol GA, Patil PP. Indian J Pathol Microbiol; 2017 Oct 01; 60(1):139-140. PubMed ID: 28195118 [No Abstract] [Full Text] [Related]
36. Multiple myeloma with skin involvement. Güvenç B, Canataroğlu A, Gümürdülü Y, Gümürdülü D, Paydaşt S. J Eur Acad Dermatol Venereol; 2001 Jul 01; 15(4):328-9. PubMed ID: 11730044 [Abstract] [Full Text] [Related]
37. Myeloma proteins in adult Chinese patients. Lin KT. Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1977 Jun 01; 10(1-2):28-36. PubMed ID: 408113 [No Abstract] [Full Text] [Related]
38. Peroxiredoxin I is differentially expressed in multiple myelomas and in plasmablastic lymphomas. Demasi AP, Magalhães MH, Furuse C, Araújo NS, Junqueira JL, Araújo VC. Oral Dis; 2008 Nov 01; 14(8):741-6. PubMed ID: 18565146 [Abstract] [Full Text] [Related]
39. Dynamic follow-up of smoldering multiple myeloma identifies a subset of patients at high risk of progression. Gran C, Luong V, Bruchfeld JB, Liwing J, Afram G, Lund J, Usmani S, Alici E, Nahi H. Am J Hematol; 2021 Mar 01; 96(3):E63-E65. PubMed ID: 33264449 [No Abstract] [Full Text] [Related]